Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (43)
Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche
1931 • 2,994 citations
Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
1992 • 1,025 citations
Immunology Taught by Viruses
1996 • 656 citations
Medicine and the Law
1987 • 541 citations
A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques
1989 • 419 citations
The Simian Immunodeficiency Viruses
1990 • 387 citations
The Complete Nucleotide Sequence of a Pathogenic Molecular Clone of Simian Immunodeficiency Virus
1990 • 335 citations
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus
1996 • 325 citations
Simian immunodeficiency virus DNA vaccine trial in macaques
1996 • 240 citations
Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.
1990 • 216 citations
Antiviral Antibody Responses and Intrauterine Transmission after Primary Maternal Cytomegalovirus Infection
1995 • 187 citations
Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques
1992 • 177 citations
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus
1995 • 173 citations
Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process
1997 • 170 citations
Recent rubella virus infection indicated by a low avidity of specific IgG
1988 • 169 citations
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge
1994 • 142 citations
Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity
1991 • 125 citations
Analysis of Envelope Changes Acquired by SIVmac239 during Neuroadaption in Rhesus Macaques
1993 • 97 citations
The Ability of Certain SIV Vaccines to Provoke Reactions Against Normal Cells
1992 • 87 citations
Transmissible Lymphoma and Simian Acquired Immunodeficiency Syndrome in Rhesus Monkeys<xref ref-type="fn" rid="FN1">2</xref>
1986 • 80 citations
Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell Lines
1990 • 79 citations
Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection
1993 • 74 citations
Avidity of IgG antibodies to human herpesvirus‐6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross‐reactivity with other herpesviruses
1993 • 69 citations
Varicella‐zoster virus antibody avidity and IgG‐subclass patterns in children with recurrent chickenpox
1994 • 66 citations
Antibody avidity following varicella‐zoster virus infections
1991 • 64 citations
Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (Avidity‐ELISA) and by haemolysis typing
1989 • 62 citations
Avidities of IgG directed against viral capsid antigen or early antigen: Useful markers for significant epstein‐barr virus serology
1994 • 60 citations
Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody
1994 • 60 citations
Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1
1996 • 58 citations
A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of rival glycoproteins in microtiter wells coated with concanavalin A
1990 • 57 citations
Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation
1995 • 50 citations
Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection
1992 • 48 citations
Efficacy of SIV/DeltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys
1991 • 45 citations
Rubella-specific IgG1 avidity: a comparison of methods
1991 • 43 citations
Evaluation of protein‐denaturing immunoassays for avidity of immunoglobulin G to rubella virus
1994 • 33 citations
Studies of Complement-Activating Antibodies in the SIV/Macaque Model of Acute Primary Infection and Vaccine Protection
1995 • 26 citations
A longitudinal study of the IgG antibody response to HIV-1 pl7gagprotein in HIV-1+ patients with haemophilia: titre and avidity
1993 • 19 citations
Characterization of Protective and Enhancing Immune Responses to Equine Infectious Anemia Virus Resulting from Experimental Vaccines
1996 • 19 citations
Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection.
1993 • 16 citations
Antibody affinity and protection in virus infections
1991 • 15 citations
Vaccines against Retroviruses
1995 • 13 citations
Analysis of Envelope Glycoprotein-Specific Antibodies from SIV-Infected and gp110-Immunized Monkeys in ACC and ADCC Assays
1995 • 11 citations
The Human Immunodeficiency Viruses
1995 • 7 citations